306 related articles for article (PubMed ID: 31795252)
1. Triterpenes and Aromatic Meroterpenoids with Antioxidant Activity and Neuroprotective Effects from
Wang C; Liu X; Lian C; Ke J; Liu J
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795252
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective and antioxidant lanostanoid triterpenes from the fruiting bodies of Ganoderma atrum.
Qiu J; Wang X; Song C
Fitoterapia; 2016 Mar; 109():75-9. PubMed ID: 26709153
[TBL] [Abstract][Full Text] [Related]
3. Triterpenes and Meroterpenes with Neuroprotective Effects from Ganoderma leucocontextum.
Chen H; Zhang J; Ren J; Wang W; Xiong W; Zhang Y; Bao L; Liu H
Chem Biodivers; 2018 May; 15(5):e1700567. PubMed ID: 29603608
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antioxidant potentials of an ethanolic extract of Ganoderma lucidum in rat mammary carcinogenesis.
Deepalakshmi K; Mirunalini S; Krishnaveni M; Arulmozhi V
Chin J Nat Med; 2013 Nov; 11(6):621-7. PubMed ID: 24345503
[TBL] [Abstract][Full Text] [Related]
5. Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3.
Hsieh TC; Wu JM
Int J Mol Med; 2011 Dec; 28(6):1065-9. PubMed ID: 21887458
[TBL] [Abstract][Full Text] [Related]
6. Lanostane triterpenes from the fruiting bodies of Ganoderma lucidum and their inhibitory effects on adipocyte differentiation in 3T3-L1 Cells.
Lee I; Seo J; Kim J; Kim H; Youn U; Lee J; Jung H; Na M; Hattori M; Min B; Bae K
J Nat Prod; 2010 Feb; 73(2):172-6. PubMed ID: 20039640
[TBL] [Abstract][Full Text] [Related]
7. Accessing biological actions of Ganoderma secondary metabolites by in silico profiling.
Grienke U; Kaserer T; Pfluger F; Mair CE; Langer T; Schuster D; Rollinger JM
Phytochemistry; 2015 Jun; 114():114-24. PubMed ID: 25457486
[TBL] [Abstract][Full Text] [Related]
8. Australeols A-F, neuroprotective meroterpenoids from Ganoderma australe.
Zhang JJ; Dong Y; Qin FY; Cheng YX
Fitoterapia; 2019 Apr; 134():250-255. PubMed ID: 30825574
[TBL] [Abstract][Full Text] [Related]
9. Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum.
Lee I; Ahn B; Choi J; Hattori M; Min B; Bae K
Bioorg Med Chem Lett; 2011 Nov; 21(21):6603-7. PubMed ID: 21924611
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer Effects of a Neutral Triterpene Fraction from Ganoderma lucidum and its Active Constituents on SW620 Human Colorectal Cancer Cells.
Li P; Liu L; Huang S; Zhang Y; Xu J; Zhang Z
Anticancer Agents Med Chem; 2020; 20(2):237-244. PubMed ID: 31749435
[TBL] [Abstract][Full Text] [Related]
11. A new lanostane-type triterpene from the fruiting bodies of Ganoderma lucidum.
Luo J; Zhao YY; Li ZB
J Asian Nat Prod Res; 2002 Jun; 4(2):129-34. PubMed ID: 12067158
[TBL] [Abstract][Full Text] [Related]
12. Spiro Meroterpenoids from Ganoderma applanatum.
Luo Q; Wei XY; Yang J; Luo JF; Liang R; Tu ZC; Cheng YX
J Nat Prod; 2017 Jan; 80(1):61-70. PubMed ID: 27996259
[TBL] [Abstract][Full Text] [Related]
13. Lanostane triterpenoids with cytotoxic activities from the fruiting bodies of Ganoderma hainanense.
Ma QY; Luo Y; Huang SZ; Guo ZK; Dai HF; Zhao YX
J Asian Nat Prod Res; 2013 Nov; 15(11):1214-9. PubMed ID: 23909866
[TBL] [Abstract][Full Text] [Related]
14. Triterpenes and meroterpenes from Ganoderma lucidum with inhibitory activity against HMGs reductase, aldose reductase and α-glucosidase.
Chen B; Tian J; Zhang J; Wang K; Liu L; Yang B; Bao L; Liu H
Fitoterapia; 2017 Jul; 120():6-16. PubMed ID: 28527898
[TBL] [Abstract][Full Text] [Related]
15. Triterpene antioxidants from ganoderma lucidum.
Zhu M; Chang Q; Wong LK; Chong FS; Li RC
Phytother Res; 1999 Sep; 13(6):529-31. PubMed ID: 10479768
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic lanostane-type triterpenoids from the fruiting bodies of Ganoderma lucidum and their structure-activity relationships.
Chen S; Li X; Yong T; Wang Z; Su J; Jiao C; Xie Y; Yang BB
Oncotarget; 2017 Feb; 8(6):10071-10084. PubMed ID: 28052025
[TBL] [Abstract][Full Text] [Related]
17. Triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH.
Lin YX; Sun JT; Liao ZZ; Sun Y; Tian XG; Jin LL; Wang C; Leng AJ; Zhou J; Li DW
Fitoterapia; 2022 Apr; 158():105161. PubMed ID: 35217118
[TBL] [Abstract][Full Text] [Related]
18. Meroterpenoids and alkaloids from
Zhang JJ; Dong Y; Qin FY; Yan YM; Cheng YX
Nat Prod Res; 2021 Oct; 35(19):3226-3232. PubMed ID: 31741407
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of Ganoderma lucidum triterpenes.
Wu TS; Shi LS; Kuo SC
J Nat Prod; 2001 Aug; 64(8):1121-2. PubMed ID: 11520245
[TBL] [Abstract][Full Text] [Related]
20. Lanostane triterpenoids from Ganoderma lucidum and their inhibitory effects against FAAH.
Li DW; Liu M; Leng YQ; Hu JF; Deng S; Leng AJ; Ma XC; Wang RY; Zhou J; Wang C
Phytochemistry; 2022 Nov; 203():113339. PubMed ID: 35961409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
